名称 | 銘柄コード | 市場 | 種別 |
---|---|---|---|
Connect Biopharma Holdings Inc | CNTB | NASDAQ | Depository Receipt |
始値 | 安値 | 高値 | 終値 | 前日終値 |
---|---|---|---|---|
1.37 |
最新ニュース
日付 | 時間 | ソース | タイトル |
---|---|---|---|
2024/2/28 | 11:00 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |
2024/2/14 | 06:30 | EDGAR2 | Form SC 13D - General statement of acquisition of beneficial.. |
2024/2/14 | 06:27 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
2024/2/14 | 06:18 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
2024/2/13 | 06:50 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
2023/12/12 | 20:10 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
2023/11/21 | 20:13 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
2023/11/02 | 04:57 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
2023/10/21 | 05:44 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
2023/9/13 | 05:47 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
2023/9/12 | 19:13 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |
2023/7/15 | 06:00 | EDGAR2 | Form 6-K - Report of foreign issuer [Rules 13a-16 and.. |